CCI Rejects Excessive Pricing Allegations Against Super-Specialty Hospital for Lack of Comparable Evidence

Vivek Sharma Vs Max Multi Specialty Centre (Competition Commission of India) The Competition Commission of India (CCI) examined allegations arising from Information filed under Section 19(1)(a) of the Competition Act, 2002 against Becton Dickinson India (P) Ltd. and Max Super Specialty Hospital, Patparganj, Delhi. The Informant alleged that disposable syringes manufactured by Becton Dickinson India (P) Ltd. carried higher Maximum Retail Prices (MRPs) when sold through the hospital’s in-house pharmacy compared to identical products sold in the open market. After a preliminary inquiry, the CCI...